Do online doctors check PMP for Topamax?

If you’re struggling with Binge Eating Disorder (BED), you might wonder whether you can access treatment from the comfort of your home. The short answer is yes—telehealth has become a viable, legal, and increasingly common way to receive care for BED, including prescription medications.

As of 2026, most states allow healthcare providers to prescribe non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion) via telehealth without requiring an in-person visit. However, the rules vary significantly by state, and understanding these differences can help you navigate your treatment options with confidence.

This comprehensive guide breaks down everything you need to know about accessing BED medication through telehealth—from federal regulations and state-specific requirements to provider qualifications, safety considerations, and what to expect during your virtual visit.

Understanding Telehealth Regulations for BED Medications

Federal Rules: What Applies to Non-Controlled Medications?

The foundation of telehealth prescribing regulations comes from federal law, particularly the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. This law was designed to prevent illegal online pharmacies from dispensing controlled substances (like opioids or stimulants) without proper medical oversight.

Here’s the crucial detail many patients don’t realize: The Ryan Haight Act only applies to controlled substances. Medications commonly used off-label for BED—such as Topamax and Wellbutrin—are not controlled substances under federal law. This means they were never subject to the strict in-person examination requirements that apply to medications like Adderall or Xanax.

What this means for you: Federal law does not require an in-person visit before your provider can prescribe Topamax or Wellbutrin via telehealth. These medications can be legally prescribed after a thorough virtual evaluation, as long as the provider is licensed in your state and follows appropriate clinical standards.

The DEA’s 2026 Extension: What Changed (and What Didn’t)

In January 2026, the Drug Enforcement Administration (DEA) announced its fourth extension of COVID-19-era telehealth flexibilities for controlled substances, pushing the deadline to December 31, 2026. While this extension primarily affects medications like stimulants and opioids, it reinforces the broader trend: telehealth is here to stay.

For patients seeking BED treatment with non-controlled medications, these DEA extensions don’t directly change your access—because you already had it. However, they signal regulatory stability and continued government support for telehealth services overall.

Why State Laws Matter More Than You Think

While federal law sets the baseline, state medical boards and legislatures determine the specific requirements for telehealth practice within their borders. This is where things get more nuanced.

Some states have embraced fully remote care with minimal restrictions, while others require periodic in-person follow-ups or maintain collaborative practice requirements for nurse practitioners and physician assistants. Understanding your state’s particular rules will help you know what to expect when you seek telehealth care for BED.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Breakdown: Where Can You Get BED Medication via Telehealth?

States with No In-Person Requirements

The majority of states now allow telehealth prescribing of non-controlled medications without any mandatory in-person visits. These include:

California has emerged as one of the most telehealth-friendly states. In 2025, Assembly Bill 1503 expanded the definition of ‘good faith examination’ to explicitly include asynchronous telehealth (such as secure messaging or questionnaires), as long as the standard of care is met. California also grants nurse practitioners full practice authority after three years of experience, meaning an NP can independently evaluate and treat your BED via telehealth without physician oversight.

New York allows unrestricted telehealth prescribing for non-controlled medications. While the state implemented new in-person requirements for controlled substances in May 2025, these rules don’t affect Topamax or Wellbutrin. New York NPs also have full practice authority after completing 3,600 supervised clinical hours, expanding access to qualified mental health providers.

Texas permits telehealth prescribing without in-person visits for non-controlled medications. However, nurse practitioners and physician assistants must work under a prescriptive authority agreement with a physician. This doesn’t limit your access—it’s simply a behind-the-scenes regulatory requirement that ensures collaborative oversight.

Delaware has no in-person examination requirement for non-controlled medications. The state recently clarified its telehealth laws in 2025 (Senate Bill 101) to explicitly allow medication-assisted treatment for opioid use disorder via telemedicine, demonstrating continued support for expanded telehealth access. Delaware NPs can practice independently after two years of collaborative practice.

Michigan and Wisconsin both joined the ranks of full-practice states for nurse practitioners in 2025, expanding the pool of providers who can independently treat BED via telehealth. Neither state requires in-person visits for non-controlled prescriptions.

Florida has no in-person requirement for non-controlled medications, though it maintains restrictions on Schedule II controlled substances. NPs and PAs must work under physician supervision, but this collaborative model still allows full telehealth prescribing access for BED medications.

States Requiring Periodic In-Person Follow-Ups

A handful of states allow telehealth to initiate treatment but require eventual in-person contact for ongoing care:

Alabama permits telehealth evaluations and prescribing, but if a patient receives more than four telehealth visits for the same condition within 12 months, an in-person exam must occur within that year. This in-person visit can be with any provider in the practice (not necessarily the original telehealth provider), which offers flexibility for patients using multi-provider platforms.

Georgia requires providers to attempt an annual in-person examination for patients receiving ongoing telemedicine care. The initial evaluation can be done via telehealth if it’s clinically equivalent to an in-person exam, but the state expects some in-person contact at least once per year for continued treatment.

New Hampshire updated its telehealth laws in August 2025 to remove previous barriers to remote prescribing. While the state now allows even controlled substances to be prescribed via telehealth, it requires a subsequent in-person examination within 12 months for ongoing controlled medication management. For non-controlled BED medications, this requirement is less strict, but periodic in-person follow-up is recommended as best practice.

Understanding the ‘Standard of Care’ Requirement

Even in states without explicit in-person mandates, all telehealth providers must meet the same standard of care as they would for in-person visits. This means:

• Conducting a thorough medical history review
• Assessing your symptoms and ruling out other conditions
• Discussing risks, benefits, and alternatives to medication
• Obtaining informed consent for treatment
• Documenting your care appropriately

Reputable telehealth platforms build these requirements into their clinical workflows, ensuring you receive quality care that meets both legal and ethical standards.

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathic medicine can prescribe Topamax and Wellbutrin in all 50 states via telehealth, provided they hold a valid license in the state where you’re located at the time of the consultation.

Nurse Practitioners (NPs)

The landscape for NP practice has evolved dramatically. As of 2025, 34 states plus Washington, D.C. grant nurse practitioners full practice authority, meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

Recent additions to this list include:

• Wisconsin (August 2025 APRN Modernization Act)
• Michigan (Public Act 47 of 2023, implemented 2025)
• Kansas and Louisiana (both achieved full practice authority in 2023-2024)

In full-practice states, an NP specializing in mental health or eating disorders can provide complete BED treatment via telehealth—from initial evaluation through ongoing medication management—without requiring physician collaboration.

In states requiring collaborative agreements (such as Texas, Florida, and Georgia), NPs can still prescribe BED medications via telehealth, but they work under a formal agreement with a supervising or collaborating physician. From a patient perspective, this usually doesn’t affect your experience—you’ll still see the NP for your appointments, and the collaboration happens behind the scenes.

Physician Assistants (PAs)

Physician assistants can prescribe non-controlled medications in all states, but they universally work under physician supervision or collaboration. The specific requirements vary by state, but PAs are well-qualified to manage BED treatment via telehealth within their scope of practice.

Why Provider Type Matters for Access

The expansion of NP full practice authority has significantly improved telehealth access, especially in underserved areas. Platforms like Klarity Health often employ both physicians and nurse practitioners, allowing them to serve patients across multiple states while maintaining compliance with varying scope-of-practice regulations.

When you book a telehealth appointment, the platform will match you with a provider licensed and authorized to practice in your state—whether that’s an MD, DO, NP, or PA. All of these professionals are qualified to evaluate and treat BED using evidence-based approaches.

Medications Used for BED: What You Need to Know

Topamax (Topiramate): Off-Label but Effective

FDA Approval Status: Approved for seizure disorders and migraine prevention—not approved for BED
Why It’s Used: Studies suggest topiramate may help reduce binge eating episodes by affecting appetite regulation and impulse control
Typical Starting Dose: 25-50 mg daily, gradually titrated upward
Maximum Duration via Telehealth: Up to 90-day supply with refills (state-dependent)

What You Should Know:

Topiramate requires careful titration—starting at a low dose and slowly increasing to minimize side effects. Common side effects include tingling in hands and feet (paresthesias), cognitive changes (difficulty with word-finding or concentration), and taste changes (especially with carbonated beverages).

Critical Safety Warning: Topiramate carries significant pregnancy risks, including increased chance of cleft palate and other birth defects when taken during the first trimester. If you’re of childbearing potential, your provider will discuss contraception requirements before starting this medication. Women who are pregnant, planning pregnancy, or breastfeeding are generally not candidates for topiramate treatment.

Because topiramate can affect thinking and cognitive function, your provider will schedule regular follow-ups to monitor for these effects. Most patients tolerate the medication well at lower doses, but it’s important to report any concerning symptoms immediately.

When to Avoid Topiramate:

• Pregnancy or planning to become pregnant
• History of kidney stones
• Glaucoma (especially narrow-angle)
• Metabolic acidosis
• Severe cognitive impairment

Wellbutrin (Bupropion): Depression Treatment with BED Benefits

FDA Approval Status: Approved for depression and smoking cessation—not approved for BED
Why It’s Used: May reduce binge eating frequency; some evidence suggests it helps with impulse control and mood regulation in BED patients
Typical Starting Dose: 150 mg extended-release once daily
Maximum Duration via Telehealth: Up to 90-day supply with refills

What You Should Know:

Bupropion is unique among antidepressants because it doesn’t typically cause weight gain and may even promote modest weight loss in some patients. However, it comes with important safety considerations.

Black Box Warning: Like all antidepressants, bupropion carries a warning about increased risk of suicidal thoughts and behaviors in patients under 25 years old, especially during the first few months of treatment. Your provider will monitor you closely for mood changes, particularly at the beginning of treatment.

Absolute Contraindications:
Bupropion should never be used in patients with:

• Current or past eating disorders involving purging (bulimia or anorexia nervosa) — this significantly increases seizure risk
• Seizure disorders or conditions that lower seizure threshold
• Abrupt withdrawal from alcohol or sedatives
• Current use of MAO inhibitors

The seizure risk is dose-dependent, which is why providers are careful not to exceed maximum recommended doses and why patients with bulimia or anorexia are excluded—purging behaviors and electrolyte imbalances further lower the seizure threshold.

Monitoring Requirements:

• Regular blood pressure checks (bupropion can increase BP)
• Mood and suicidality screening, especially in first 8 weeks
• Alcohol use assessment (combining with alcohol increases seizure risk)
• Sleep and anxiety monitoring (can cause insomnia or agitation in some patients)

Why These Medications Are Prescribed Off-Label

You might wonder why your telehealth provider would prescribe medications not specifically FDA-approved for BED. Off-label prescribing is completely legal and extremely common in medical practice—studies suggest that up to 20% of all prescriptions written in the U.S. are for off-label uses.

For BED specifically, the only FDA-approved medication is Vyvanse (lisdexamfetamine), which is a Schedule II controlled substance. Due to stricter telehealth regulations around controlled medications and abuse potential concerns, most telehealth platforms focus on non-controlled alternatives supported by clinical evidence.

Research has shown that both topiramate and bupropion can be effective for some BED patients:

• A 2020 meta-analysis found topiramate significantly reduced binge eating frequency compared to placebo
• Studies of bupropion in BED patients with concurrent depression showed improvements in both mood and eating behaviors
• Both medications have been included in treatment guidelines as options when first-line therapy (such as cognitive behavioral therapy) is insufficient or unavailable

Your provider should clearly explain that they’re prescribing off-label, discuss the evidence supporting this use, and obtain your informed consent. This transparency is a hallmark of quality telehealth care.

The Telehealth Evaluation Process: What to Expect

Before Your Appointment

Most telehealth platforms require you to complete a comprehensive intake questionnaire before your first visit. This typically covers:

Medical History:

• Current and past medical conditions
• All medications and supplements you’re taking
• Allergies and adverse reactions
• Surgical history
• Family medical history

Mental Health History:

• Previous diagnoses (depression, anxiety, ADHD, etc.)
• Past therapy or psychiatric treatment
• Current symptoms and how long you’ve experienced them
• Any history of self-harm or suicidal thoughts

Eating Disorder Specific Questions:

• Frequency and nature of binge eating episodes
• Foods typically consumed during binges
• Emotional triggers for binge eating
• Whether you experience compensatory behaviors (purging, excessive exercise, fasting)
• Impact on daily functioning and quality of life
• Previous eating disorder treatment

Lifestyle Factors:

• Alcohol and substance use
• Sleep patterns
• Exercise habits
• Support system and living situation

This detailed information helps your provider understand your complete clinical picture before your video consultation begins.

During Your Virtual Visit

A thorough initial BED evaluation via telehealth typically lasts 30-45 minutes—significantly longer than a medication refill visit. During this time, your provider will:

Establish the Diagnosis:
Using DSM-5 criteria, your provider will assess whether you meet the clinical definition of Binge Eating Disorder:

• Recurrent episodes of eating large amounts of food in a discrete period (typically within 2 hours)
• Feeling a lack of control during these episodes
• Binge eating episodes associated with three or more of these features:
• Eating much more rapidly than normal
• Eating until uncomfortably full
• Eating large amounts when not physically hungry
• Eating alone due to embarrassment
• Feeling disgusted, depressed, or guilty afterward
• Marked distress about binge eating
• Binging occurs at least once weekly for three months
• Binge eating is not associated with compensatory behaviors (which would suggest bulimia nervosa)

Rule Out Other Conditions:
Your provider will ensure your symptoms aren’t better explained by other diagnoses such as bulimia nervosa, major depression with atypical features, or medical conditions affecting appetite and eating (like Prader-Willi syndrome or certain neurological disorders).

Assess Safety for Medication:
Before prescribing, your provider will specifically screen for contraindications:

• For topiramate: pregnancy status, history of kidney stones, glaucoma
• For bupropion: history of seizures, current/past bulimia or anorexia, alcohol use patterns

Discuss Treatment Options:
A comprehensive provider won’t jump straight to medication. They should discuss:

• Psychotherapy: Cognitive Behavioral Therapy (CBT) is considered first-line treatment for BED and has strong evidence for effectiveness
• Nutritional counseling: Working with a registered dietitian specializing in eating disorders
• Support groups: Peer support through organizations like Overeaters Anonymous or NEDA
• Medication: When therapy alone isn’t sufficient, or when you prefer a combined approach

Obtain Informed Consent:
Your provider should clearly explain:

• Why they’re recommending a specific medication
• That it’s being used off-label for BED
• Common side effects and how to manage them
• Serious risks and contraindications
• What to do if you experience concerning symptoms
• The importance of follow-up appointments

Create a Treatment Plan:
Together, you’ll establish:

• Starting medication dose and titration schedule
• Follow-up appointment timeline (usually 2 weeks initially, then monthly)
• Monitoring plan (what symptoms to track)
• Additional support resources

After Your Appointment

Your provider will electronically send your prescription to a pharmacy of your choice—this is now required in most states and helps ensure you’re receiving legitimate, FDA-approved medication from a licensed pharmacy.

You should receive:

• Written care instructions or a visit summary
• Information about potential side effects
• Emergency contact information if you experience severe reactions
• A scheduled follow-up appointment (typically within 2-4 weeks)

Red Flag Warning: If a telehealth service prescribes medication after a 5-10 minute consultation without asking detailed questions about your eating patterns, mental health history, and medical contraindications, that’s a serious concern. Quality BED care requires thorough evaluation—shortcuts could compromise your safety.

Who Should NOT Pursue Telehealth Treatment for BED

While telehealth has expanded access to BED treatment, it’s not appropriate for everyone. Responsible providers will screen out patients who need higher levels of care.

Medical Instability

If your binge eating has led to severe medical complications requiring close monitoring, you may need in-person treatment. This includes:

• Severe electrolyte imbalances
• Unstable diabetes with frequent hypoglycemia or DKA
• Heart rhythm abnormalities
• Severe hypertension or other cardiovascular concerns
• Significant weight fluctuations requiring medical supervision

Active Purging Behaviors

If you engage in compensatory behaviors (self-induced vomiting, laxative abuse, excessive exercise to ‘undo’ binges), you likely have bulimia nervosa rather than BED, and you’re not a candidate for bupropion due to seizure risk. You may need specialized eating disorder treatment beyond what telehealth can safely provide.

Suicidal Ideation or Severe Depression

While telehealth can treat depression, active suicidal thinking or severe depressive symptoms (psychotic features, inability to care for yourself) require immediate in-person or crisis intervention. Most telehealth platforms will refer you to emergency services or intensive outpatient programs if you’re experiencing acute mental health crisis.

Pregnancy and Breastfeeding

Topiramate is generally avoided in pregnancy due to teratogenic risks. While some medications can be used cautiously during breastfeeding, the risk-benefit analysis for BED medications in pregnant or breastfeeding patients typically favors non-medication approaches like therapy.

Need for Controlled Substance Treatment

If clinical evaluation suggests you would benefit from Vyvanse (the only FDA-approved medication for BED, which is a controlled substance), most telehealth platforms cannot prescribe this due to more restrictive regulations around controlled substances. You would likely be referred to an in-person specialist.

Complex Medical or Psychiatric Comorbidities

If you have multiple complex conditions requiring coordination among several specialists, or if you have treatment-resistant mental health conditions, you may be better served by comprehensive in-person care where providers can collaborate more easily.

Important: Being excluded from telehealth treatment doesn’t mean you can’t get help—it means you need a different level of care. Reputable telehealth providers will connect you with appropriate resources rather than attempting to treat conditions beyond their safe scope.

Ensuring Safety and Quality in Telehealth BED Treatment

The rapid expansion of telehealth during the COVID-19 pandemic brought unprecedented access—but also raised concerns about quality and safety. High-profile cases, such as the 2024 indictment of executives from a telehealth startup for unsafe ADHD medication prescribing, highlighted the risks of inadequate clinical oversight.

How to Identify Reputable Telehealth Providers

Verify Licensing:
Every provider should be licensed in the state where you’re physically located during the appointment. Legitimate platforms clearly display provider credentials and state licenses. Don’t hesitate to verify a provider’s license through your state medical or nursing board website.

Look for Comprehensive Evaluations:
Quality care requires time. Initial BED evaluations should be 30+ minutes. Platforms that promise prescriptions after a brief questionnaire or 5-minute video chat are not providing appropriate clinical care.

Transparent Prescribing Policies:
Reputable platforms clearly state what they don’t prescribe. For example, many telehealth services for mental health explicitly note they don’t prescribe controlled substances like stimulants or benzodiazepines. This transparency demonstrates they’re prioritizing safety over profit.

Evidence of Clinical Protocols:
Good telehealth platforms have clear clinical guidelines their providers follow. Look for mentions of:

• Screening tools and standardized assessments
• Medication selection criteria
• Follow-up and monitoring requirements
• Pathways for escalating care when needed

Legitimate Pharmacy Relationships:
Your prescription should be sent to a licensed pharmacy you choose—CVS, Walgreens, local independents, or verified mail-order pharmacies. Be wary of services that want to directly ship medication from their own ‘pharmacy’ without using established dispensing channels.

What Quality Telehealth Should Include

Identity and Location Verification:
At the start of your visit, you’ll be asked to verify your identity (often by showing ID) and confirm your location. This isn’t invasive—it’s required to ensure your provider is licensed where you are and helps prevent fraud.

Documentation and Records:
You should have access to your medical records, visit notes, and treatment plans through a secure patient portal. Transparency in documentation is both a legal requirement and a mark of quality care.

Continuity of Care:
Ideally, you’ll see the same provider for follow-up appointments, or at minimum, providers will have access to your complete history within the platform. Fragmented care with no records transfer is a red flag.

Communication Between Visits:
Quality platforms offer secure messaging for questions between visits, and clear protocols for urgent concerns (e.g., ‘If you experience X, Y, or Z, contact us immediately or go to the ER’).

Medication Monitoring:
For medications like topiramate and bupropion, your provider should:

• Schedule regular follow-ups to assess effectiveness and side effects
• Adjust dosing based on your response
• Be prepared to discontinue medication if it’s not helping or causing problems
• Check in about any new medications or health changes that might interact

When Platforms Like Klarity Health Can Help

Klarity Health exemplifies many of these quality markers. The platform connects patients with licensed psychiatrists and psychiatric nurse practitioners who specialize in mental health conditions including eating disorders.

Key advantages include:

• Provider Availability: Book appointments quickly without months-long waits common in traditional practice
• Transparent Pricing: Clear upfront costs for both insurance and self-pay patients—no surprise bills
• Dual Payment Options: Accept both insurance and cash pay, making care accessible regardless of coverage status
• Licensed Providers: All clinicians are licensed in the states where they practice, ensuring legal and ethical compliance
• Comprehensive Care: Focus on thorough evaluations rather than quick prescriptions, with evidence-based treatment protocols

While Klarity Health can facilitate access to BED medication treatment via telehealth where appropriate, they also screen for cases better suited to in-person care and help coordinate referrals when needed.

Navigating Insurance, Costs, and Prescriptions

Insurance Coverage for Telehealth

The good news: most insurance plans now cover telehealth at the same rate as in-person visits. The Mental Health Parity and Addiction Equity Act requires that mental health services, including telehealth for conditions like BED, be covered equivalently to other medical services.

However, coverage specifics vary:

• Some plans require copays for telehealth just like office visits
• Others may have lower copays for virtual visits
• Out-of-network telehealth providers may result in higher out-of-pocket costs

Check Before You Book:

• Verify whether your telehealth platform is in-network with your insurance
• Ask about copay amounts for initial evaluation vs. follow-up visits
• Clarify whether prescriptions are covered under your pharmacy benefit

Cash-Pay Options

If you don’t have insurance or your plan doesn’t cover telehealth mental health services, many platforms offer transparent cash-pay pricing:

Typical Cash-Pay Costs:

• Initial evaluation: $150-$300
• Follow-up visits (15-30 min): $75-$150
• Medication costs: Varies by drug and pharmacy
• Topiramate (generic): Often $20-$40/month without insurance
• Bupropion (generic): Typically $10-$30/month without insurance

Platforms like Klarity Health offer clear upfront pricing, so you know costs before you book—no hidden fees or surprise bills.

Prescription Savings

Even if your insurance covers the visit, medication costs can vary widely:

Ways to Save:

• Ask for generic versions (available for both topiramate and bupropion)
• Use prescription discount cards (GoodRx, SingleCare, RxSaver)
• Check pharmacy prices—they can vary significantly
• Ask about 90-day supplies, which are often cheaper than filling monthly

Your telehealth provider can send prescriptions to any pharmacy, so you can price-shop or use a mail-order service if that’s more affordable.

The Future of BED Treatment via Telehealth

Regulatory Trends

The overall trajectory is toward maintaining and expanding telehealth access, with appropriate safeguards:

What’s Likely to Continue:

• Unrestricted telehealth prescribing for non-controlled medications (like BED treatments)
• Insurance parity for telehealth mental health services
• Interstate licensure compacts allowing providers to serve patients in multiple states

What’s Evolving:

• More formalized standards for clinical protocols in telehealth
• Enhanced verification and fraud prevention measures
• Possible permanent rules for controlled substance prescribing via telehealth (currently under DEA review)

What to Watch:

• The DEA is expected to issue final rules on telehealth controlled substance prescribing by the end of 2026. While this won’t affect Topamax or Wellbutrin, it could impact future access to Vyvanse via telehealth if approved.
• States continue to expand NP scope of practice—as more states grant full practice authority, access to specialized mental health providers via telehealth will grow.

Technology Advances

Future telehealth for BED may incorporate:

• Smartphone apps for tracking eating episodes, mood, and triggers between appointments
• Integration with wearables to monitor physiological markers
• AI-assisted screening tools to help identify BED earlier
• Hybrid models combining telehealth medication management with app-based CBT modules

Integrated Care Models

The most effective BED treatment combines medication (when appropriate) with therapy and nutritional support. Telehealth platforms are increasingly partnering with:

• Therapists specializing in CBT for eating disorders
• Registered dietitians offering virtual nutrition counseling
• Support groups and peer coaching programs

This integrated approach—coordinated through a single platform—may become the standard of care, making comprehensive BED treatment more accessible than ever.

Taking the Next Step: How to Start Telehealth BED Treatment

Step 1: Assess Your Readiness

Ask yourself:

• Have I experienced recurrent binge eating episodes (at least weekly for 3+ months)?
• Do I feel distressed by these episodes?
• Am I ready to commit to regular appointments and follow treatment recommendations?
• Do I have any of the contraindications mentioned (pregnancy, seizure history, active purging)?

If you’re unsure whether your symptoms meet BED criteria, that’s okay—the evaluation process will help clarify this.

Step 2: Choose a Reputable Platform

Look for:

• Clear provider credentials and licensing information
• Transparent pricing
• Good patient reviews (but be wary of platforms with only 5-star reviews—that can indicate fake reviews)
• Comprehensive intake process
• Clear policies on prescribing and follow-up care

Platforms like Klarity Health offer these features, with the added benefit of flexible scheduling and both insurance and cash-pay options.

Step 3: Prepare for Your First Appointment

Gather:

• Current medication list (including over-the-counter and supplements)
• Medical history summary (past diagnoses, surgeries)
• Insurance information (if using insurance)
• List of questions or concerns you want to address

Consider tracking:

• Frequency and circumstances of binge episodes for a week or two before your appointment
• Mood patterns
• Any triggers you’ve noticed

This preparation helps your provider understand your situation quickly and thoroughly.

Step 4: Be Honest and Thorough

The quality of care you receive depends on the information you provide. Be candid about:

• The extent and frequency of binge eating
• Any purging or compensatory behaviors
• Substance use, including alcohol
• Mental health symptoms
• Previous treatment attempts and their outcomes

Remember: providers are there to help, not judge. Comprehensive, honest information enables them to create the most effective treatment plan for you.

Step 5: Commit to Follow-Through

Starting medication is just the beginning:

• Attend scheduled follow-up appointments
• Report side effects or concerns promptly
• Be patient—medications may take several weeks to show benefits
• Consider complementary therapy or counseling
• Track your progress (many find it helpful to journal about eating patterns and mood)

Step 6: Know When to Seek Additional Support

Telehealth medication management works best when combined with other supports:

• Individual or group therapy
• Nutritional counseling
• Support groups (in-person or online)
• Mindfulness or stress-reduction practices

If medication alone isn’t providing sufficient benefit, discuss expanding your treatment team with your provider.

Frequently Asked Questions

Can I get a prescription for BED medication in my first telehealth visit?
Possibly, yes—if you meet diagnostic criteria and have no contraindications. However, a responsible provider will conduct a thorough evaluation first (30-45 minutes). If everything checks out and medication is appropriate, they can send a prescription that same day. Don’t expect a prescription from a 5-minute chat—that’s a red flag, not efficient care.

Will my insurance cover telehealth for eating disorders?
Most insurance plans cover telehealth mental health services, including for eating disorders, at the same rate as in-person visits. However, coverage specifics vary by plan. Contact your insurance company or check with the telehealth platform about in-network status before booking.

Do I need to see the same provider every time?
Continuity is ideal but not always required. Many platforms allow you to see your preferred provider for follow-ups, which helps with ongoing relationship and care coordination. If you must see a different provider, they should have access to your full medical record within the platform.

How long will I need to take medication for BED?
This varies by individual. Some people benefit from several months of medication combined with therapy, then successfully discontinue. Others find longer-term medication helpful for maintaining recovery. Your provider will regularly reassess whether medication continues to provide benefit and whether the risk-benefit balance supports continuation.

What if the medication doesn’t work or causes side effects?
Contact your provider promptly. They can adjust the dose, switch to a different medication, or recommend discontinuing if side effects outweigh benefits. Never stop medications like topiramate abruptly—they require gradual tapering to prevent withdrawal seizures.

Can I get Vyvanse (the FDA-approved BED medication) via telehealth?
Currently, most telehealth platforms do not prescribe Vyvanse or other controlled substances for BED due to stricter regulations. However, this may change if the DEA implements new permanent rules allowing controlled substance prescribing via telehealth. For now, Vyvanse typically requires in-person evaluation.

What happens if I move to a different state?
Your provider must be licensed in the state where you’re physically located during the appointment. If you move, you may need to find a new provider licensed in your new state, or check if your current provider holds licenses in multiple states.

Can teenagers get BED treatment via telehealth?
Yes, but with parent/guardian involvement. Minors require parental consent for treatment. Some platforms specialize in adolescent eating disorders and have providers experienced in this age group. Note that bupropion carries increased suicide risk warnings for those under 25, so extra monitoring is essential.

Key Takeaways

Telehealth has revolutionized access to Binge Eating Disorder treatment, making care available to people who might otherwise face months-long waits or lack local specialists. Here’s what you need to remember:

✅ Non-controlled medications like Topamax and Wellbutrin can be legally prescribed via telehealth in all 50 states without federal in-person requirements

✅ State laws vary—most allow fully remote care, while a few (like Alabama and Georgia) require periodic in-person follow-ups

✅ Comprehensive evaluation matters—quality providers take 30+ minutes for initial assessments and screen carefully for contraindications

✅ Both physicians and NPs can prescribe—with 34+ states now granting NPs full practice authority, expanding the provider pool

✅ Off-label use is legal and common—Topamax and Wellbutrin aren’t FDA-approved for BED specifically, but have clinical evidence supporting their use

✅ Safety comes first—certain

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12